Armata Pharmaceuticals, Inc.

AMEX: ARMP · Healthcare · Biotechnology

PublicHQ Marina del Rey, CA · Los AngelesCIK 0000921114Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 27DQ —GM —SS 72

v0.1 · 35/100 weight · pillars only

↑ listing tenure, market scale · ↓ balance-sheet leverage, return on assets

Methodology →

Revenue TTM

$3.0M

Rev growth YoY (TTM)

-37.1%

Net income (FY)

-$173.8M

Employees

Market cap

$216.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$173.8M-$173.8M2025

Operating income-$36.6M-$36.6M2025

Total assets$76.9M$76.9M2025

Liabilities$295.5M$295.5M2025

Equity-$218.6M-$218.6M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Armata Pharmaceuticals, Inc. earned -$173.8M in FY2025 net income.

Peers · Healthcare

Karyopharm Therapeutics Inc.49D Spok Holdings, Inc.83B+Avalo Therapeutics, Inc.41D Nautilus Biotechnolgy, Inc.——

Neighbors

Los Angeles →

The Walt Disney Company$94.4B71B Rocket Lab USA, Inc.$601.8M50D Public Storage$4.8B79B+Live Nation Entertainment, Inc.$25.2B76B+Ares Management Corporation$5.6B67B Edison International$19.3B81B+

Key facts

CEODeborah L. Birx

SectorHealthcare

IndustryBiotechnology

HeadquartersMarina del Rey, CA

ExchangeAMEX: ARMP

Employees60

IPO date1994-05-20

Latest filings

8-K2026-06-23 8-K2026-06-16 10-Q2026-05-13 8-K2026-05-13 8-K2026-05-07 8-K2026-04-27 DEF 14A2026-04-27 8-K2026-04-02

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.